The global bone growth stimulators market size was US$ 1197.06 million in 2021. The global bone growth stimulators market size is forecast to reach US$ 2109.9 million by 2030, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2022 to 2030.
An electrical or ultrasound stimulation that promotes bone growth and speeds up bone healing is delivered by a bone growth stimulator. For patients with a history of smoking, this device is advised by several orthopedic doctors. They also advise using this gadget when blood flow is compromised and open wounds, fracture patterns, and bones do not heal adequately. Additionally, the use of the device is advised during cervical or spinal fusion procedures. Small incisions and less blood loss are just two advantages associated with minimally invasive and non-invasive surgical procedures.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic had a negative impact on the global market growth. The daily operations of numerous healthcare services, including bone growth stimulation therapy methods, have been affected by the changed standard operating protocols reviewed by the regulatory authorities and the integration of social distancing norms. The majority of healthcare facilities suspended or delayed routine care due to the COVID-19 pandemic, and emergency care was provided by the hospitals. Thus, the delayed and postponed appointments and the problematic application of bone growth stimulation had a negative impact on market demand in the first half of 2020.
Regional Analysis
North America accounted for a major market share in 2021 and is forecast to remain dominant during the forecast period. As a result of the increasing healthcare expenditures, growing prevalence, and incidences of related bone disorders. In addition, the National Spinal Cord Injury Statistical Center evaluates that 296,000 people in the United States have spinal cord injuries (SCI), ranging from 252,000 to 373,000. Thus, the growing prevalence of spinal cord injuries will lead to the demand for bone growth stimulators, an increase in the geriatric population, and a growing patient inclination for minimally-invasive orthopedic treatments. Thus, these factors drive the market growth in the region.
Leading Competitors
The leading prominent companies profiled in the global bone growth stimulators market are:
Scope of Report
The global bone growth stimulators market segmentation focuses on Type, Application, End-User, and Region.
Segmentation based on Type
Segmentation based on Application
Segmentation based on End-User
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL BONE GROWTH STIMULATORS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL BONE GROWTH STIMULATORS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL BONE GROWTH STIMULATORS MARKET, BY TYPE
5.1 OVERVIEW
5.2 BONE GROWTH STIMULATION DEVICES
5.2.1 ELECTRICAL BONE GROWTH STIMULATORS
5.2.1.1 PULSED ELECTROMAGNETIC FIELD (PEMF) DEVICES
5.2.1.2 CAPACITIVE COUPLING (CC) DEVICES
5.2.1.3 COMBINED MAGNETIC FIELD (CMF) DEVICES
5.2.2 ULTRASONIC BONE GROWTH STIMULATORS
5.2.3 IMPLANTED BONE GROWTH STIMULATORS
5.2.3.1 RICH PLASMA (PRP) THERAPY
5.2.3.2 BONE MORPHOGENETIC PROTEINS (BMP)
6 GLOBAL BONE GROWTH STIMULATORS MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 ORAL AND MAXILLOFACIAL SURGERIES
6.3 DELAYED UNION & NONUNION BONE FRACTURES
6.4 SPINAL FUSION SURGERIES
6.5 OTHERS
7 GLOBAL BONE GROWTH STIMULATORS MARKET, BY GEOGRAPHY
7.1 OVERVIEW
7.2 NORTH AMERICA
7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO
7.3 EUROPE
7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3.1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE
7.4 ASIA PACIFIC
7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC
7.5 MIDDLE EAST & AFRICA
7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA
7.6 SOUTH AMERICA
7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA
8 GLOBAL BONE GROWTH STIMULATORS MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES
9 COMPANY PROFILES
9.1 ARTHREX, INCORPORATED
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS
9.2 ISTO BIOLOGICS
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS
9.3 ZIMMER BIOMET HOLDINGS, INCORPORATED
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS
9.4 COLFAX CORPORATION (DJO GLOBAL, INCORPORATED)
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS
9.5 TERUMO CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS
9.6 JOHNSON & JOHNSON (DEPUY SYNTHES)
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS
9.7 ESSEX WOODLANDS HEALTHCARE PARTNERS (BIOVENTUS LLC)
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS
9.8 MEDTRONIC PLC.
9.8.1 OVERVIEW
9.8.2 FINANCIAL PERFORMANCE
9.8.3 PRODUCT OUTLOOK
9.8.4 KEY DEVELOPMENTS
9.9 ORTHOFIX MEDICAL INCORPORATED
9.9.1 OVERVIEW
9.9.2 FINANCIAL PERFORMANCE
9.9.3 PRODUCT OUTLOOK
9.9.4 KEY DEVELOPMENTS
9.10 STRYKER CORPORATION
9.10.1 OVERVIEW
9.10.2 FINANCIAL PERFORMANCE
9.10.3 PRODUCT OUTLOOK
9.10.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved